Heise T - Search Results

1

Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.

Heise T, Mathieu C. Heise T, et al. Diabetes Obes Metab. 2017 Jan;19(1):3-12. doi: 10.1111/dom.12782. Epub 2016 Sep 26. Diabetes Obes Metab. 2017. PMID: 27593206 Free PMC article. Review.

2

Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.

Heinemann L, Weyer C, Rave K, Stiefelhagen O, Rauhaus M, Heise T. Heinemann L, et al. Among authors: heise t. Exp Clin Endocrinol Diabetes. 1997;105(3):140-4. doi: 10.1055/s-0029-1211742. Exp Clin Endocrinol Diabetes. 1997. PMID: 9228509 Clinical Trial.

3

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture.

Weyer C, Heise T, Heinemann L. Weyer C, et al. Among authors: heise t. Diabetes Care. 1997 Oct;20(10):1612-4. doi: 10.2337/diacare.20.10.1612. Diabetes Care. 1997. PMID: 9314644 Clinical Trial.

4

Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.

Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L. Heise T, et al. Diabetes Care. 1998 May;21(5):800-3. doi: 10.2337/diacare.21.5.800. Diabetes Care. 1998. PMID: 9589244 Clinical Trial.

5

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.

Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T. Heinemann L, et al. Among authors: heise t. Diabetes Care. 1998 Nov;21(11):1910-4. doi: 10.2337/diacare.21.11.1910. Diabetes Care. 1998. PMID: 9802742 Clinical Trial.

6

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Heinemann L, et al. Among authors: heise t. Diabetes Care. 2000 May;23(5):644-9. doi: 10.2337/diacare.23.5.644. Diabetes Care. 2000. PMID: 10834424 Clinical Trial.

7

Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.

Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T. Heinemann L, et al. Among authors: heise t. Diabetes Care. 2000 Sep;23(9):1343-7. doi: 10.2337/diacare.23.9.1343. Diabetes Care. 2000. PMID: 10977030 Clinical Trial.

8

Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT. Rave K, et al. Among authors: heise t. Diabetes Care. 2001 May;24(5):886-90. doi: 10.2337/diacare.24.5.886. Diabetes Care. 2001. PMID: 11347749

9

[Clinical effects and pharmacodynamics of insulin analogs lispro, aspart and glargin].

Heinemann L, Heise T. Heinemann L, et al. Among authors: heise t. Dtsch Med Wochenschr. 2001 May 18;126(20):597-604. doi: 10.1055/s-2001-14106. Dtsch Med Wochenschr. 2001. PMID: 11402927 Review. German. No abstract available.

10

Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force.

Heinemann L, Krämer U, Klötzer HM, Hein M, Volz D, Hermann M, Heise T, Rave K; Non-Invasive Task Force. Heinemann L, et al. Among authors: heise t. Diabetes Technol Ther. 2000 Summer;2(2):211-20. doi: 10.1089/15209150050025168. Diabetes Technol Ther. 2000. PMID: 11469261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results